Qualitative prediction of blood-brain barrier permeability on a large and refined dataset
- PMID: 22109848
- PMCID: PMC3241963
- DOI: 10.1007/s10822-011-9478-1
Qualitative prediction of blood-brain barrier permeability on a large and refined dataset
Abstract
The prediction of blood-brain barrier permeation is vitally important for the optimization of drugs targeting the central nervous system as well as for avoiding side effects of peripheral drugs. Following a previously proposed model on blood-brain barrier penetration, we calculated the cross-sectional area perpendicular to the amphiphilic axis. We obtained a high correlation between calculated and experimental cross-sectional area (r = 0.898, n = 32). Based on these results, we examined a correlation of the calculated cross-sectional area with blood-brain barrier penetration given by logBB values. We combined various literature data sets to form a large-scale logBB dataset with 362 experimental logBB values. Quantitative models were calculated using bootstrap validated multiple linear regression. Qualitative models were built by a bootstrapped random forest algorithm. Both methods found similar descriptors such as polar surface area, pKa, logP, charges and number of positive ionisable groups to be predictive for logBB. In contrast to our initial assumption, we were not able to obtain models with the cross-sectional area chosen as relevant parameter for both approaches. Comparing those two different techniques, qualitative random forest models are better suited for blood-brain barrier permeability prediction, especially when reducing the number of descriptors and using a large dataset. A random forest prediction system (n(trees) = 5) based on only four descriptors yields a validated accuracy of 88%.
Figures
Similar articles
-
Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands.J Pharm Pharm Sci. 2013;16(4):622-47. doi: 10.18433/j3jk5p. J Pharm Pharm Sci. 2013. PMID: 24210068
-
ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.J Chem Inf Comput Sci. 2003 Nov-Dec;43(6):2137-52. doi: 10.1021/ci034134i. J Chem Inf Comput Sci. 2003. PMID: 14632466
-
Analysing molecular polar surface descriptors to predict blood-brain barrier permeation.Int J Comput Biol Drug Des. 2013;6(1-2):146-56. doi: 10.1504/IJCBDD.2013.052195. Epub 2013 Feb 21. Int J Comput Biol Drug Des. 2013. PMID: 23428480
-
In silico prediction of blood-brain barrier permeation.Drug Discov Today. 2003 Oct 15;8(20):927-33. doi: 10.1016/s1359-6446(03)02827-7. Drug Discov Today. 2003. PMID: 14554156 Review.
-
[Computer modeling of blood brain barrier permeability of physiologically active compounds].Biomed Khim. 2014 Mar-Apr;60(2):161-81. doi: 10.18097/pbmc20146002161. Biomed Khim. 2014. PMID: 24837308 Review. Russian.
Cited by
-
In Silico and In Vitro Analyses to Repurpose Quercetin as a Human Pancreatic α-Amylase Inhibitor.ACS Omega. 2023 Nov 10;8(46):43617-43631. doi: 10.1021/acsomega.3c05082. eCollection 2023 Nov 21. ACS Omega. 2023. PMID: 38027372 Free PMC article.
-
A machine learning-based quantitative model (LogBB_Pred) to predict the blood-brain barrier permeability (logBB value) of drug compounds.Bioinformatics. 2023 Oct 3;39(10):btad577. doi: 10.1093/bioinformatics/btad577. Bioinformatics. 2023. PMID: 37713469 Free PMC article.
-
Explaining Blood-Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms.J Med Chem. 2023 Jun 8;66(11):7253-7267. doi: 10.1021/acs.jmedchem.2c01824. Epub 2023 May 22. J Med Chem. 2023. PMID: 37217193
-
Integrated approach for studying bioactive compounds from Cladosporium spp. against estrogen receptor alpha as breast cancer drug target.Sci Rep. 2022 Dec 27;12(1):22446. doi: 10.1038/s41598-022-22038-x. Sci Rep. 2022. PMID: 36575224 Free PMC article.
-
In Vitro and In Silico Studies for the Identification of Potent Metabolites of Some High-Altitude Medicinal Plants from Nepal Inhibiting SARS-CoV-2 Spike Protein.Molecules. 2022 Dec 15;27(24):8957. doi: 10.3390/molecules27248957. Molecules. 2022. PMID: 36558090 Free PMC article.
References
-
- Bradbury MWB. The blood-brain barrier. Exp Physiol. 1993;78(4):453–472. - PubMed
-
- Wager TT, Chandrasekaran RY, Hou X, Troutman MD, Verhoest PR, Villalobos A, Will Y. Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes. ACS Chem Neurosci. 2010;1(6):420–434. doi: 10.1021/cn100007x. - DOI - PMC - PubMed
-
- Lacombe O, Guyol AC, Videau O, Pruvost A, Bolze S, Prevost C, Mabondzo A. Brain penetration predictivity using in vitro primary rat and human cell-based blood-brain barrier models for drug discovery and development. Fundam Clin Pharmacol. 2010;24:8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
